Cigna Investments’s Synaptics SYNA Stock Holding History

Cigna Investments’s Portfolio SYNA Stock Details SYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-868	Closed	-$252K	–	651
2021 Q4	$252K	Sell	868 -250	-22%	-$59.7K	0.02%	565
2021 Q3	$201K	Buy	+1,118	New	+$188K	0.02%	714

Other funds holding SYNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cigna Investments's SYNA Position: Q1 2022 in Review

Cigna Investments sold out of Synaptics (SYNA) in Q1 2022, closing a stake of 868 shares — an estimated $252K sold.

Cigna Investments first reported a position in SYNA in Q3 2021 and held it in 2 quarters. The position peaked at $252K in Q4 2021. 369 funds tracked by Wall St. Rank hold SYNA as of Q1 2022.

Cigna Investments reported no remaining Synaptics position as of Q1 2022 after selling out during the quarter.
Cigna Investments sold 868 Synaptics shares in Q1 2022, an estimated $252K.
Cigna Investments first reported a position in Synaptics in Q3 2021 and held it in 2 quarters.
Cigna Investments's Synaptics position peaked at $252K in Q4 2021.
369 funds tracked by Wall St. Rank held Synaptics as of Q1 2022.

Based on Cigna Investments's 13F filing for Q1 2022, filed 13 May 2022.